HTA - 06/303/205

A randomised phase III trial of Docetaxel plus Prednisolone vs. Docetaxel with Prednisolone plus either Zoledronic acid, Strontium-89 or both agents combined (TRAPEZE)

Project title: A randomised phase III trial of Docetaxel plus Prednisolone vs. Docetaxel with Prednisolone plus either Zoledronic acid, Strontium-89 or both agents combined (TRAPEZE)

Call to action: 06/303 HTA Clinical Trials - Pharmaceutical Panel

Research type: Primary Research

Chief investigator: Professor Nicholas James

Lead Author: Professor Nicholas James

Contractor: University of Birmingham

Cost: £749,088.58

Co-investigators: Dr Emilio Porfiri, Professor Lucinda Billingham, Professor Stirling Bryan.

Started: April 2007 | Status: Published July 2016

ISRCTN: 12808747

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.